Oliceridine Dose for Tracheal Intubation Hemodynamic Elevation: Up-and-Down Trial

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 4, 2025

Primary Completion Date

September 11, 2025

Study Completion Date

September 11, 2025

Conditions
Oliceridine
Interventions
DRUG

Oliceridine Injection

"Adult participants receive a single IV bolus of oliceridine (initial dose 45 µg/kg for ages 18-65 y or 40 µg/kg for ≥65 y). Two minutes later, propofol 2 mg/kg IV is administered. Upon loss of consciousness (MOAA/S ≤ 1), rocuronium 0.6 mg/kg IV is given. Direct laryngoscopic tracheal intubation is performed after full muscle relaxation. Blood pressure and heart rate are recorded at baseline, 2 min post-oliceridine, immediately pre-intubation, and for 3 min post-intubation. A positive hemodynamic response is defined as ≥ 20% increase in MAP or HR, HR ≥ 120 bpm, or SBP ≥ 180 mmHg. Subsequent oliceridine doses are adjusted ± 3 µg/kg based on the prior patient's response until seven response crossovers are observed, allowing estimation of ED₅₀ and ED₉₅."

Trial Locations (1)

431700

Tianmen First People's Hospital, Tianmen

All Listed Sponsors
lead

Shiyou Wei

OTHER